Editorial comment on Differences in overall survival of penile cancer patients vs. population‐based controls

Documenti analoghi

• Prognostic factors for overall survival in clinical node‐positive patients with upper tract urothelial carcinoma
  di: Taishiro Sasahara, et al.
  Pubblicazione: (2024)
• Publication of patient series, particularly on rare tumors such as penile cancer, necessitates the contextualization of presented data with guideline recommendations
  di: Matthias May, et al.
  Pubblicazione: (2024)
• The correlation between discrepancies in clinical and pathological T stages and overall survival in upper urinary tract urothelial carcinoma: Analysis of the hospital‐based cancer registry data in Japan
  di: Masanobu Shiga, et al.
  Pubblicazione: (2025)
• Sexuality in penile cancer survivors: A rarely discussed problem in uro‐oncology
  di: Hilary Mosquera Angulo, et al.
  Pubblicazione: (2024)
• Enfortumab vedotin prolongs overall survival in metastatic urothelial carcinoma following pembrolizumab therapy in real‐world data
  di: Koichi Uemura, et al.
  Pubblicazione: (2024)